243 related articles for article (PubMed ID: 35965328)
21. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro-oncogenic phenotype in HNSCC.
Gracilla DE; Korla PK; Lai MT; Chiang AJ; Liou WS; Sheu JJ
Mol Oncol; 2020 Dec; 14(12):3065-3082. PubMed ID: 32979859
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck.
Xu T; Yu CY; Sun JJ; Liu Y; Wang XW; Pi LM; Tian YQ; Zhang X
Arch Med Res; 2011 Feb; 42(2):128-37. PubMed ID: 21565626
[TBL] [Abstract][Full Text] [Related]
24. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
[TBL] [Abstract][Full Text] [Related]
26. Prolyl 4-hydroxylase subunit alpha 3 presents a cancer promotive function in head and neck squamous cell carcinoma via regulating epithelial-mesenchymal transition.
Wang T; Wang YX; Dong YQ; Yu YL; Ma K
Arch Oral Biol; 2020 May; 113():104711. PubMed ID: 32220804
[TBL] [Abstract][Full Text] [Related]
27. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
[TBL] [Abstract][Full Text] [Related]
28. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Smith A; Teknos TN; Pan Q
Oral Oncol; 2013 Apr; 49(4):287-92. PubMed ID: 23182398
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
30. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33322834
[TBL] [Abstract][Full Text] [Related]
31. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma.
Srivastava C; Irshad K; Gupta Y; Sarkar C; Suri A; Chattopadhyay P; Sinha S; Chosdol K
BMC Cancer; 2020 Jan; 20(1):62. PubMed ID: 31992226
[TBL] [Abstract][Full Text] [Related]
32. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
33. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
[TBL] [Abstract][Full Text] [Related]
34. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
35. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
36. Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.
Sugiyama Y; Shelley EJ; Badouel C; McNeill H; McAvoy JW
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4099-107. PubMed ID: 26114487
[TBL] [Abstract][Full Text] [Related]
37. FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma.
Hu X; Zhai Y; Shi R; Qian Y; Cui H; Yang J; Bi Y; Yan T; Yang J; Ma Y; Zhang L; Liu Y; Li G; Zhang M; Cui Y; Kong P; Cheng X
Oncol Rep; 2018 May; 39(5):2136-2146. PubMed ID: 29565465
[TBL] [Abstract][Full Text] [Related]
38. Control of mitochondrial function and cell growth by the atypical cadherin Fat1.
Cao LL; Riascos-Bernal DF; Chinnasamy P; Dunaway CM; Hou R; Pujato MA; O'Rourke BP; Miskolci V; Guo L; Hodgson L; Fiser A; Sibinga NE
Nature; 2016 Nov; 539(7630):575-578. PubMed ID: 27828948
[TBL] [Abstract][Full Text] [Related]
39. Comparative integromics on FAT1, FAT2, FAT3 and FAT4.
Katoh Y; Katoh M
Int J Mol Med; 2006 Sep; 18(3):523-8. PubMed ID: 16865240
[TBL] [Abstract][Full Text] [Related]
40. Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin.
Nishikawa Y; Miyazaki T; Nakashiro K; Yamagata H; Isokane M; Goda H; Tanaka H; Oka R; Hamakawa H
Oncol Rep; 2011 Sep; 26(3):587-92. PubMed ID: 21617878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
